NCT04739319Recruiting
Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression
Source: ClinicalTrials.gov · Last updated 9 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss worldwide, and nearly two million Australians have some signs of AMD. This proposed project is a prospective, observational study that seeks to to understand the underlying aetiology of AMD, factors associated with differences between age-related macular degeneration (AMD) phenotypes or severities, or between AMD and healthy individuals. It also seeks to understand the natural history of AMD progression and the factors associated with the rate of progression. In this project, the disease phenotype, genotype and severity and rate of progression will be determined based on non-invasive clinical imaging or functional assessment of the retina, from obtaining biological samples from the participants, or from patient-reported outcomes.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2500 (estimated)
- First submitted
- 1 Feb 2021
- Start date
- 2 Feb 2021
- Primary completion date
- Nov 2040
- Lead sponsor
- Center for Eye Research Australia
- Diseases
- Macular degeneration
- NCT number
- NCT04739319
What you commit to
- Study type: Observational
- Planned participants: 2500
- From 2 Feb 2021 to the primary completion date, Nov 2040
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- ocular or systemic conditions other than AMD that could compromise retinal assessment or assessment of AMD and its progression; or
- any participant with any mental or physical impairment that prevents them from signing an informed consent form or participating in this study.
Who the study is looking for
- 18 years of age or older; and
- either AMD (defined as having at least a medium druse \>63 um), or having eyes with normal ageing changes (including small drusen ≤63 um) or no abnormalities as control participants
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Eye Research Australia Coordinator of this site? Confirm its status | East Melbourne | Australia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.